Cerebral MRI in neurological asymptomatic patients with malignant melanoma;Zerebrales MRT bei neurologisch asymptomatischen patienten mit malignem melanom

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 180, Issue 2, 2008, Pages 143-147

  Schlamann, Marc ^a   Loquai, C ^b   Goericke, S ^a   Forsting, M ^a   Wanke, I ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Brain; Melanoma; Metastases; MR imaging; Staging

Indexed keywords

CONTRAST MEDIUM;

ARTICLE; BRAIN METASTASIS; CANCER STAGING; CONTROLLED STUDY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MELANOMA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 39149108485     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963711     Document Type: Article

References (23)

1. Tarhini AA, Agarwala SS. Management of brain metastases in patients with melanoma. Curr Opin Oncol 2004; 16: 161-166
2. Schultz ES, Schuler G. Malignes Melanom. Diagnostik und Therapie. HNO 2005; 53: 928-939
3. Balch CM, Buzaid AC, Soong SJ et al. Final version of the American Joint Committee on Cancer Staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 3635-3648
4. Garbe C, Hauschild A, Volkenandt M et al. Kurzleitlinie: Malignes Melanom der Haut. J Dtsch Dermatol Ges 2006; 4: 344-349
5. Sampson JH, Carter JH, Friedman AH et al. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998; 88: 11-20
6. Johnson JD, Young B. Demographics of brain metastasis. Neurosurg Clin N Am 1996; 7: 337-344
7. Zacest AC, Besser M, Stevens G et al. Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades. J Neurosurg 2002; 96: 552-558
8. Buchsbaum JC, Suh JH, Lee SY et al. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study. Cancer 2002; 94: 2265-2272
9. Douglas JG, Margolin K. The treatment of brain metastases from malignant melanoma. Semin Oncol 2002; 29: 518-524
10. Buzaid AC, Tinoco L, Ross MI et al. Role of computed tomography in the staging of patients with local-regional metastases of melanoma. J Clin Oncol 1995; 13: 2104-2108
11. Argyriou AA, Chroni E, Polychronopoulos P et al. Headache characteristics and brain metastases prediction in cancer patients. Eur J Cancer Care 2006; 15: 90-95
12. Brown PD, Brown CA, Pollock BE et al. Stereotactic radiosurgery for patients with "radioresistant" brain metastases. Neurosurgery 2002; 51: 656-665
13. Miranda EP, Gertner M, Wall J et al. Routine imaging of asymptomatic melanoma patients with metastasis to sentinel lymph nodes rarely identifies systemic disease. Arch Surg 2004; 139: 831-836
14. Zartman GM, Thomas MR, Robinson WA. Metastatic disease in patients with newly diagnosed malignant melanoma. J Surg Oncol 1987; 35: 163-164
15. Reider-Groswasser I, Merimsky O, Karminsky N et al. Computed tomography features of cerebral spread of malignant melanoma. Am J Clin Oncol 1996; 19: 49-53
16. Fogarty GB, Tartaguia C. The utility of magnetic resonance imaging in the detection of brain metastases in the staging of cutaneous melanoma. Clin Oncol (R Coll Radiol) 2006; 18: 360-362
17. Garbe C, Blum A. Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol 2001; 14: 280-290
18. Garbe C, Büttner B, Bertz J et al. Primary cutaneous melanoma prognostic classification of anatomic location. Cancer 1995; 75: 2492-2498
19. Gaviani P, Mullins ME, Braga TA et al. Improved detection of metastatic melanoma by T2*-weighted imaging. AJNR Am J Neuroradiol 2006; 27: 605-608
20. Harting I, Hartmann M, Sartor K. Tumor-simulierende Läsionen in der kranialen MRT. Fortschr Röntgenstr 2004; 176: 302-312
21. Muller-Horvat C, Radny P, Eigentler TK et al. Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma. Eur J Cancer 2006; 42: 342-350
22. Pfannenberg C, Aschoff P, Schanz S et al. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomographyand whole-body magnetic resonance imaging in staging of advanced malignant melanoma. European Journal of Cancer 2007; 43: 557-564
23. Ladd SC, Zenge M, Antoch G et al. MR-Ganzkörperdiagnostik. Fortschr Röntgenstr 2006; 178: 763-770